期刊名称：Farmeconomia. Health economics and therapeutic pathways
印刷版ISSN：2240-256X
出版年度：2008
卷号：9
期号：1S
页码：67-69
DOI：10.7175/fe.v9i1S.1013
语种：English
出版社：SEEd
摘要：In Molise region 48,4% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 8 cases of cervicocarcinoma and 3 related deaths and thus results to be cost-effective (18.457 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 8 cancer cases and 4 deaths could be prevented, with a very similar cost-effectiveness ratio. In Molise region, the net cost for woman vaccinated is 191 € for the single cohort and 194 € for the multiple cohort.
